Concorde Asset Management, LLC Invitae Corp Transaction History

Concorde Asset Management, LLC

  • $159 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 20, 2021
SELL
$26.09 - $40.4 $214,094 - $331,522
-8,206 Closed
0 $0
Q1 2021

Apr 27, 2021
SELL
$33.06 - $56.93 $487,337 - $839,205
-14,741 Reduced 64.24%
8,206 $314,000
Q4 2020

Jan 29, 2021
SELL
$39.09 - $57.4 $339,262 - $498,174
-8,679 Reduced 27.44%
22,947 $959,000
Q3 2020

Oct 23, 2020
BUY
$28.43 - $44.67 $899,127 - $1.41 Million
31,626 New
31,626 $1.37 Million

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Concorde Asset Management, LLC Portfolio

Follow Concorde Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concorde Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email